PMCL (.03) Pharm Control Announces New Product Developments
NEW YORK, NY -- (MARKET WIRE) -- April 18, 2007 -- Pharm Control (PINKSHEETS: PMCL) is proud to announce that the Company is intensely researching and developing a new product that is an all-natural medication to reduce blood pressure for high blood pressure sufferers. The Company hopes to bring this product to market shortly both in Europe and North America were the market for such a product is high.
In regard to Shareholder Update dated April 5, 2007, the Company anticipates the name change to Natural Medications Inc. and the new CUSIP number will be completed in the upcoming weeks.
About Pharm Control Ltd.
Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.
Safe Harbor Statement
The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
AI
